Dr Reddy's Launches Oral Semaglutide Biosimilar Obeda In India
Dr Reddy's Launches Oral Semaglutide Biosimilar Obeda In India
Dr Reddy's Launches Oral Semaglutide Biosimilar Obeda In India
Sector
HEALTHCARE
News Type
MARKET
Impact Level
LOW
AI Sentiment
NEUTRAL
Published
19 Jun 2026
📎 Sources
Reuters | https://www.tradingview.com/news/reuters.com,2026:newsml_FWN41X0FK:0-dr-reddy-s-launches-oral-semaglutide-biosimilar-obeda-in-india/